Shanghai Hutchison Pharmaceuticals
CompanyChina
Shanghai Hutchison Pharmaceuticals develops one asset, in phase 3 (SHPL-49 in acute ischemic stroke). Mostly small molecule; based in China.
- 1
- Asset
- Furthest stage
- Phase 3
- 3
- Trials
- 0
- Signals
Pipeline
1Investigational drug for acute ischemic stroke
Phase 3, Small molecule, acute ischemic stroke
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Trials4
- Signals1
- Similar companies6